Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

12345678910

LONDON BRIEFING: GSK hails pipeline as ups 2031 sales target

5th Feb 2025 07:49

(Alliance News) - European blue-chips are set for a softer open, as the equity market continues to be marred by trade tensions this week. Read More

IN BRIEF: Indivior completes USD100 million share buyback

4th Feb 2025 10:41

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use disorders - Completes share buyback programme begun in July. Indivior buys back 9.4 million shares at average GBP8.25, worth GBP77.7 million, about USD100.0 million, in total. The buyback was run by Morgan Stanley & Co International PLC. Last week, Indivior promoted David Wheadon to chair, starting immediately. Wheadon joined the Indivior board in June last year. Wheadon is a medical doctor who worked for GlaxoSmithKline, now GSK PLC, and Eli Lilly & Co. Until 2019, he was senior vice president of global regulatory affairs, patient safety & quality assurance at AstraZeneca PLC. Read More

UK earnings, trading statements calendar - next 7 days

29th Jan 2025 11:47

Read More

GSK applications for sinus disease treatment accepted for review

28th Jan 2025 09:10

(Alliance News) - GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal polyps, or CRSwNP, have been accepted for review in China, Japan and the EU. Read More

LONDON MARKET CLOSE: FTSE 100 steady but Deepseek sparks US tech rout

27th Jan 2025 16:59

(Alliance News) - London's blue-chips closed little changed on Monday amid a heavy sell-off in global technology stocks, including a 17% drop for chip maker Nvidia. Read More

GSK and University of Oxford researchers to create cancer vaccine

27th Jan 2025 09:05

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. Read More

GSK shingles treatment application accepted for review in Europe

27th Jan 2025 08:49

(Alliance News) - GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment for shingles. Read More

LONDON BRIEFING: Diageo rules out Guinness sale; Dr Martens backs view

27th Jan 2025 07:47

(Alliance News) - London's FTSE 100 is called to open lower on Monday, ahead of a slew of interest rate decisions this week, and as investors continue to track any policy giveaways from the new Donald Trump US administration. Read More

LONDON BROKER RATINGS: Jefferies raises Spirax; Peel Hunt cuts Grainger

20th Jan 2025 09:56

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

20th Jan 2025 08:40

(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or recurrent endometrial cancer eligible for systemic therapy. Read More

UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale

15th Jan 2025 08:43

(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securities PLC confirmed on Wednesday. Read More

Pfizer to more than halve Haleon holding in GBP2.57 billion sale

14th Jan 2025 17:24

(Alliance News) - Pfizer Inc is selling 700 million shares in Haleon PLC, more than halving its remaining stake, according to a statement from JPMorgan Securities on Tuesday. Read More

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

13th Jan 2025 09:08

(Alliance News) - GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its "growing portfolio in gastrointestinal cancers". Read More

LONDON MARKET OPEN: FTSE 100 down, Reeves fails to lift mood

13th Jan 2025 09:03

(Alliance News) - Stock prices in London opened in the red on Monday, after Friday's US jobs data increased expectations of a pause in rate cuts this year. Read More

LONDON BRIEFING: Stocks red, China exports surge before Trump tariffs

13th Jan 2025 07:48

(Alliance News) - The FTSE 100 was called lower on Monday, after Friday's US jobs data strengthened Federal Reserve hawks' hand and made rate cuts less likely. Read More

GSK awaits FDA review of new shingles vaccine presentation

10th Jan 2025 08:58

(Alliance News) - GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review. Read More

GSK hails FDA breakthrough therapy designation for bone cancer drug

7th Jan 2025 09:12

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer. Read More

LONDON BRIEFING: Next ups guidance after strong Christmas trade

7th Jan 2025 07:52

(Alliance News) - Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus. Read More

GSK treatment approved for adults with sinus condition in China

3rd Jan 2025 08:21

(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study. Read More

LONDON BRIEFING: Herald Investment backs record amid Saba Capital saga

3rd Jan 2025 07:41

(Alliance News) - London's FTSE 100 is called to open slightly lower on Friday, after emerging from the new year with a hefty rise on Thursday. Read More

12345678910
FTSE 100 Latest
Value8,809.74
Change53.53